Ilan Daskal
Chief Financial Officer, Bio-Rad Laboratories.
Companies
- VIAVI SolutionsChief financial officer Nov 14, 2023 to now1
- Bio-Rad LaboratoriesChief financial officer Apr 9, 2019 to Sep 6, 20232
- NATUS MEDICAL INCBoard member Mar 20, 2020 to Jul 21, 20223
- IxiaBoard member Jun 29, 2015 to Apr 20, 20174
- SunEdisonChief financial officer Apr 11, 2016 to Apr 11, 20165
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
VIAVI Solutions VIAV94,566 shares6$3.3M at $34.94Sep 22, 2026
Bio-Rad Laboratories BIO2,486 shares7$880.7K at $354.24Sep 2, 2023- NATUS MEDICAL INC0 shares8Jul 21, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 22, 2026Shares withheld for tax 32,079 shares at $36.40 of VIAVI Solutions6
- Sep 22, 2026Exercised options 71,127 shares of VIAVI Solutions6
- Sep 22, 2026Shares withheld for tax 37,285 shares at $36.40 of VIAVI Solutions6
- Sep 22, 2026Exercised options 82,671 shares of VIAVI Solutions6
- Aug 31, 2026Sold 26,033 shares at $36.29 of VIAVI Solutions9
- Aug 31, 2026Sold 30,257 shares at $36.29 of VIAVI Solutions9
- Aug 28, 2026Shares withheld for tax 21,387 shares at $36.54 of VIAVI Solutions10
- Aug 28, 2026Exercised options 47,420 shares of VIAVI Solutions10
- Aug 28, 2026Shares withheld for tax 24,857 shares at $36.54 of VIAVI Solutions10
- Aug 28, 2026Exercised options 55,114 shares of VIAVI Solutions10
- Dec 2, 2025Sold 105,191 shares at $17.43 of VIAVI Solutions11
- Dec 2, 2025Sold 39,709 shares at $17.42 of VIAVI Solutions11
- Dec 2, 2025Sold 25,100 shares at $17.84 of VIAVI Solutions11
- Nov 28, 2025Shares withheld for tax 17,084 shares at $17.94 of VIAVI Solutions12
- Nov 28, 2025Exercised options 37,879 shares of VIAVI Solutions12
- Nov 28, 2025Shares withheld for tax 29,741 shares at $17.94 of VIAVI Solutions12
- Nov 28, 2025Exercised options 65,944 shares of VIAVI Solutions12
- Nov 28, 2025Shares withheld for tax 16,229 shares at $17.94 of VIAVI Solutions12
- Nov 28, 2025Exercised options 35,984 shares of VIAVI Solutions12
- Nov 28, 2025Shares withheld for tax 28,253 shares at $17.94 of VIAVI Solutions12
- Nov 28, 2025Exercised options 62,645 shares of VIAVI Solutions12
- Sep 23, 2025Shares withheld for tax 31,816 shares at $12.41 of VIAVI Solutions13
- Sep 23, 2025Exercised options 70,545 shares of VIAVI Solutions13
- Aug 28, 2025Shares withheld for tax 24,857 shares at $11.27 of VIAVI Solutions14
- Aug 28, 2025Exercised options 55,115 shares of VIAVI Solutions14
Trade performance
| Date | Stock | Trade | Value | Return since | Vs S&P since | Vs S&P, 1 year |
|---|---|---|---|---|---|---|
| Sep 3, 2021 | BIO | Sale | $221.4K | −56.9% | +127.2% | +27.9% |
| Sep 2, 2021 | BIO | Sale | $447.1K | −57.2% | +127.5% | +28.6% |
| Aug 4, 2021 | BIO | Sale | $1.7M | −53.6% | +129.4% | +23.6% |
Returns are price-only (no dividends), measured from the trade date.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARNATUS MEDICAL INC, Board member
- 4SEC EDGARIxia, Board member
- 5SEC EDGARSunEdison, Chief financial officer
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Aug 31, 2026
- 10SEC EDGARForm 4 filed Aug 31, 2026
- 11SEC EDGARForm 4 filed Dec 3, 2025
- 12SEC EDGARForm 4 filed Dec 1, 2025
- 13SEC EDGARForm 4 filed Sep 25, 2025
- 14SEC EDGARForm 4 filed Sep 2, 2025